WAPO: Feds Look to Reign in Nonprofit Body Snatchers
Wapo ran an interesting story a few days ago about the nonprofit organ donation practice, a niche if ever there was one. It seems there is a whole Rubick’s cube of laws and regulations covering organ donations in the United States and nonprofits are right there in the middle making it all work. I asked ChatGPT for an overview of whole thing. You can read the responses below the fold.
Nonprofits are key, but in this case, some are screwing up everything. The short version is that nonprofit organ procurement organizations (OPOs) need federal certification. Certification is not mandated, exactly, but other stakeholders in the health care, research and organ transplant industry who need federal certification for their own related activities must shun the uncertified. Its actually a pretty neat system of regulating by peer pressure and ostracization rather than outright mandate. So OPOs need certification as a practical matter.
One of the requirements to be a certified OPO is that the organization collect and presumably disburse for good use a minimal level of donated organs every couple three or four years. This according to regulations adopted in 2020. Well, the struggling OPOs started gobbling up pancreata, an apparently easily obtainable human organ previously in adequate supply for different charitable purposes. When OPOs starting snatching bodies, stakeholders started worrying that the hoarding would negatively impact the whole system. The Center for Medicare & Medicaid Services (CMS), the relevant federal agency, figured out the perverse effect its 2020 regulation had on research and issued proposed regulations to fix it. The article refers to long-running active Congressional oversight jumped started recently by hearings and letters emerging in and from both Houses.
When that happens, we know there must be a lot of money in organ harvesting.
darryll k. jones
The Center for Medicare & Medicaid Services (CMS) does not directly regulate the act of organ donation itself; rather, its regulatory authority extends to the oversight of healthcare facilities and transplant centers that participate in organ transplantation. CMS’s role involves ensuring these centers meet specific conditions of participation (CoPs) that pertain to quality, safety, and efficiency in the transplantation process. This includes certification, compliance with quality standards, and enforcement actions for those not meeting requirements.
The regulation of organ donation and allocation in the United States is primarily overseen by the United Network for Organ Sharing (UNOS), which operates under the Organ Procurement and Transplantation Network (OPTN) as mandated by the National Organ Transplant Act (NOTA) of 1984. UNOS is responsible for managing the national organ transplant system, including policies and procedures for the donation, procurement, and transplantation of organs.
While CMS does not have the authority to prohibit organ donation, it can impact the transplantation process through its regulatory actions on transplant centers. For instance, if a transplant center does not comply with CMS standards, CMS can revoke its certification, effectively prohibiting the center from performing organ transplants. However, this action would be based on failure to meet healthcare standards rather than an attempt to regulate organ donation directly.
Organ donation itself is encouraged and regulated through a combination of federal laws, state regulations, and ethical guidelines designed to promote donation while protecting donors and recipients. Efforts to increase organ donation are focused on education, voluntary registration as organ donors, and ensuring ethical and equitable allocation of organs to those in need.
. . .
The Center for Medicare & Medicaid Services (CMS) plays a significant role in the regulation of organ donation in the United States, primarily through its oversight and regulation of the healthcare facilities that participate in organ transplantation. While the direct regulation of organ donation is largely under the purview of the United Network for Organ Sharing (UNOS), which operates under a contract with the federal government, CMS is involved in several key areas:
1. **Certification of Transplant Centers**: CMS establishes conditions of participation (CoPs) that hospitals and transplant centers must meet to be certified to perform organ transplants. These conditions include specific requirements for staffing, patient care, and quality outcomes. CMS certification is crucial for transplant centers because it determines their eligibility to receive federal funding and reimbursement through Medicare and Medicaid programs.
2. **Quality Assurance and Performance Improvement**: CMS requires transplant centers to engage in quality assurance and performance improvement (QAPI) programs. These programs are designed to monitor outcomes, improve patient care, and ensure the efficient use of organs for transplantation. Transplant centers must report various data points, including patient survival rates, organ rejection rates, and other performance indicators.
3. **Enforcement Actions**: If a transplant center fails to meet the established CMS standards and conditions, CMS can take enforcement actions. These actions may range from requiring the center to undertake corrective measures to revoking the center’s certification to perform organ transplants.
4. **Policy Development and Regulation**: CMS also plays a role in the broader policy development and regulatory framework affecting organ donation and transplantation. This includes regulations that impact the allocation of organs, reimbursement policies for organ procurement and transplantation, and initiatives aimed at increasing organ donation rates.
5. **Collaboration with Other Federal Agencies**: CMS collaborates with other federal agencies, such as the Health Resources and Services Administration (HRSA), which oversees the Organ Procurement and Transplantation Network (OPTN) managed by UNOS. This collaboration helps to ensure that policies and regulations across agencies are aligned and support the overall goal of increasing organ donation and transplantation rates while ensuring patient safety and equitable access.
It’s important to note that the regulatory landscape is complex and involves multiple stakeholders, including federal and state agencies, organ procurement organizations (OPOs), transplant centers, and other healthcare providers involved in the organ donation and transplantation process. CMS’s role is critical in ensuring that the healthcare aspects of the organ transplant system meet high standards of quality, safety, and equity.